Keertan Dheda

University of Cape Town (UCT) - Centre for Lung Infection and Immunity

Cape Town

South Africa

SCHOLARLY PAPERS

8

DOWNLOADS
Rank 834

SSRN RANKINGS

Top 834

in Total Papers Downloads

52,812

SSRN CITATIONS

3

CROSSREF CITATIONS

1

Scholarly Papers (8)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Federal University of São Paulo (UNIFESP), University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand, Stellenbosch University - Family Centre for Research with Ubuntu, Soweto Clinical Trials Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, GSK plc, University of Oxford - The Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, University of Liverpool - School of Tropical Medicine, University of Bristol - Bristol Vaccine Centre, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Hospital Universitário de Santa Maria, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, University of Cambridge - Department of Medicine, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group and Independent
Downloads 52,387 (51)
Citation 3

Abstract:

Loading...

2.

Diagnostic Yield of Urine Lipoarabinomannan   and Sputum Tuberculosis Tests in People Living with HIV: A Systematic Review and Meta-Analysis of Individual Participant Data

Number of pages: 29 Posted: 10 Oct 2022
Heidelberg University Hospital - Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital - Division of Infectious Disease and Tropical Medicine, Epicentre (Paris), affiliation not provided to SSRN, University College London - Institute for Global Health, University of Nantes - l’institut du thorax, University of Cape Town Lung Institute, affiliation not provided to SSRN, Istituto Superiore di Sanità - Center for Global Health, University of California, San Francisco (UCSF), affiliation not provided to SSRN, UNC Global Projects, affiliation not provided to SSRN, Epicentre (Mbarara), Médecins Sans Frontières - Southern Africa Medical Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Cape Town (UCT), Texas Biomedical Research Institute, affiliation not provided to SSRN, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, University of New South Wales (UNSW) - Kirby Institute, University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, University of Cape Town (UCT) - Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town (UCT) - Division of Clinical Pharmacology, affiliation not provided to SSRN, Stellenbosch University - DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Heidelberg University Hospital - Division of Infectious Disease and Tropical Medicine and Heidelberg University Hospital - Division of Infectious Disease and Tropical Medicine and German Centre for Infection Research
Downloads 159 (355,023)

Abstract:

Loading...

Tuberculosis, TB, Diagnostics, Xpert, Lipoarabinomannan, LAM, meta-analysis

3.

An All-Oral 6-Month Regimen for Multi-Drug Resistant/Rifampicin-Resistant Tuberculosis: A Multi-Centre, Phase 3, Open Label, Randomised Controlled Trial (NeXT Study)

Number of pages: 47 Posted: 28 Jul 2021
University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, South African Medical Research Council - Biostatistics Unit, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Sefako Makgatho Health Sciences University - Department of Intensive Care, University of the Witwatersrand - Department of Internal Medicine, Walter Sisulu University - Department of Medicine, Walter Sisulu University - Head of Pulmonology, University of Kwazulu-Natal, Don Makenzie Hospital, Harry Comay Hospital, Harry Comay Hospital, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - University of Cape Town Lung Institute, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Brooklyn Chest Hospital, Stellenbosch University - Division of Molecular Biology and Human Genetics, National Department of Health - Drug Resistant TB Directorate, University of Cape Town (UCT) - Division of Clinical Pharmacology, Stellenbosch University - Division of Molecular Biology and Human Genetics and University of the Witwatersrand - Perinatal HIV Research Unit
Downloads 109 (476,065)
Citation 1

Abstract:

Loading...

4.

Durability of ChAdOx1 nCoV-19 (AZD1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron BA.1 and BA.4 Six Months after Vaccination: A Randomised, Phase 1b/2a Trial

Number of pages: 30 Posted: 28 Jul 2022
University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand - Faculty of Health Sciences, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), Setshaba Research Centre, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Stellenbosch University - Family Centre for Research with Ubuntu, Soweto Clinical Trials Centre, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Setshaba Research Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Soweto Clinical Trials Centre, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of the Witwatersrand, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, Setshaba Research Centre, National Institute for Communicable Diseases of the National Health Laboratory Service, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of the Witwatersrand, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of the Witwatersrand and University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit
Downloads 63 (661,484)

Abstract:

Loading...

COVID-19, AZD1222, immunogenicity, durability of protection

5.

The Utility of High-Flow Nasal Oxygen for Severe COVID-19 Pneumonia in a Resource-Constrained Setting: A Multi-Centre Prospective Observational Study

Number of pages: 44 Posted: 18 Sep 2020
University of Cape Town (UCT) - University of Cape Town Lung InstituteUniversity of Cape Town (UCT) - Centre for Lung Infection and Immunity, Stellenbosch University - Division of Pulmonology, University of Cape Town (UCT) - Groote Schuur Hospital, University of Cape Town (UCT) - University of Cape Town Lung Institute, University of Cape Town (UCT) - Department of Anaesthesia and Perioperative Medicine, University of Cape Town (UCT) - Division of Infectious Diseases & HIV Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - University of Cape Town Lung Institute, University of Cape Town (UCT) - Department of Statistical Sciences, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Division of Pulmonology, University of Cape Town (UCT) - Centre for Lung Infection and Immunity and Stellenbosch University - Department of Medicine
Downloads 45 (768,334)

Abstract:

Loading...

COVID-19, ventilation, high flow nasal oxygen, pneumonia

6.

Outcomes of Patients Undergoing Lung Resection for Drug-Resistant TB and the Prognostic Significance of Pre-Operative Positron Emission Tomography/Computed Tomography (PET/CT) in Predicting Treatment Failure

Number of pages: 27 Posted: 13 Sep 2021
University of Cape Town (UCT) - University of Cape Town Lung InstituteUniversity of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Chris Barnard Division of Cardiothoracic Surgery, University of Cape Town (UCT) - Division of Nuclear Medicine, University of Cape Town (UCT) - Division of Nuclear Medicine, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, District Clinical Specialist Team, Namakwa District, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Chris Barnard Division of Cardiothoracic Surgery, University of Cape Town (UCT) - Chris Barnard Division of Cardiothoracic Surgery and University of Cape Town (UCT) - Centre for Lung Infection and Immunity
Downloads 29 (893,886)

Abstract:

Loading...

Drug-resistant tuberculosis, TB surgery, PET/CT

7.

Host-Directed Targeting of lincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium Tuberculosis

Number of pages: 39 Posted: 12 Jun 2020
International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town - Centre for Lung Infection and Immunology, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Massey University - School of Natural and Computational Sciences, Hamad Bin Khalifa University - Information and Computing Technology Division, RIKEN Center for Integrative Medical Sciences, RIKEN Center for Integrative Medical Sciences, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy and International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy
Downloads 20 (981,629)

Abstract:

Loading...

M. tuberculosis, Long non-coding RNAs, host-directed therapy, macrophages, Inflammation

8.

High Frequency of Bedaquiline Resistance in Programmatically Treated Drug-Resistant TB Patients with Sustained Culture-Positivity in Cape Town, South Africa

Posted: 30 Sep 2022
Stellenbosch University - Division of Molecular Biology and Human Genetics, University of Antwerp - Centre for Population, Family, and Health, Stellenbosch University - Division of Molecular Biology and Human Genetics, Natera, Inc., Stellenbosch University - Division of Molecular Biology and Human Genetics, Stellenbosch University - Division of Molecular Biology and Human Genetics, University of California, San Francisco (UCSF) - Division of Pulmonary and Critical Care Medicine, Stellenbosch University - Division of Molecular Biology and Human Genetics, National Health Laboratory Services (NHLS), Stellenbosch University - Division of Molecular Biology and Human Genetics, Médecins sans Frontières, Eshowe, South Africa, The Translational Genomics Research Institute (TGen), The Translational Genomics Research Institute (TGen), University of Antwerp - Centre for Population, Family, and Health, University of Basel - Swiss Tropical and Public Health Institute, Institute of Tropical Medicine - Mycobacteriology Unit, Brooklyn Chest Hospital, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Médecins sans Frontières, Eshowe, South Africa, Stellenbosch University - Division of Molecular Biology and Human Genetics, University of California, San Francisco (UCSF) - Division of Pulmonary and Critical Care Medicine, University of Cape Town (UCT) - Division of Medical Microbiology and Stellenbosch University - DST/NRF Centre of Excellence for Biomedical Tuberculosis Research

Abstract:

Loading...

Tuberculosis, drug-resistant tuberculosis, bedaquiline, novel drug, programmatic, bedaquiline-resistance, bedaquiline phenotypic DST, whole genome sequencing, targeted deep sequencing